Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 17-Apr-2014
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 16)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
16-Apr-14Pechala's ReportsLubomir PechalaBIOMARIN PHARAMACEUTICAL INC (BMRN) - REPORT FOR ACTIVE TRADERS1$25  View Abstract
16-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49  View Abstract
12-Apr-14Alpha Street ResearchHunter OrrBMRN - Biomarin Pharmaceutical Inc - Rated a Hold - Company Analysis and ASR Ranking Report9$24  View Abstract
12-Apr-14S&P Capital IQ – STARS ReportsN/ABioMarin Pharmaceutical11$126.50  View Abstract
12-Apr-14Pechala's ReportsFrantisek PechalaBIOMARIN PHARAMACEUTICAL INC (BMRN) 12-months forecast1$15  View Abstract
11-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: BIND , BMRN , NPSP , PGNX , RIGL -- DRUGS3$34.50  View Abstract
11-Apr-14Ford Investor Services, Inc.N/AValue Graph: BIOMARIN PHARM -- BMRN1$11.50  View Abstract
11-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMARIN PHARMACEUTICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
10-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for BMRN11$25  View Abstract
10-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Biomarin Pharmaceutical Inc42$75  View Abstract
Next 6

Independent Reports (Showing 1 to 10 of 16)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
16-Apr-14Pechala's ReportsLubomir PechalaBIOMARIN PHARAMACEUTICAL INC (BMRN) - REPORT FOR ACTIVE TRADERS1$25View Abstract
16-Apr-14ValuEngine, Inc.N/AValuEngine Industry Report for Medical-biomed/genetics18$49View Abstract
12-Apr-14Alpha Street ResearchHunter OrrBMRN - Biomarin Pharmaceutical Inc - Rated a Hold - Company Analysis and ASR Ranking Report9$24View Abstract
12-Apr-14S&P Capital IQ – STARS ReportsN/ABioMarin Pharmaceutical11$126.50View Abstract
12-Apr-14Pechala's ReportsFrantisek PechalaBIOMARIN PHARAMACEUTICAL INC (BMRN) 12-months forecast1$15View Abstract
11-Apr-14Ford Investor Services, Inc.N/AIndustry Value Graph: BIND , BMRN , NPSP , PGNX , RIGL -- DRUGS3$34.50View Abstract
11-Apr-14Ford Investor Services, Inc.N/AValue Graph: BIOMARIN PHARM -- BMRN1$11.50View Abstract
11-Apr-14Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of BIOMARIN PHARMACEUTICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
10-Apr-14ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for BMRN11$25View Abstract
10-Apr-14Wright ReportsN/AWright Investors Service Comprehensive Report for Biomarin Pharmaceutical Inc42$75View Abstract
Next 6

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.